SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-136212
Filing Date
2020-05-07
Accepted
2020-05-07 16:07:31
Documents
86
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d843470d10q.htm   iXBRL 10-Q 3368220
2 EX-31.1 d843470dex311.htm EX-31.1 10520
3 EX-31.2 d843470dex312.htm EX-31.2 10505
4 EX-32 d843470dex32.htm EX-32 4682
  Complete submission text file 0001193125-20-136212.txt   13469266

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA teva-20200331.xsd EX-101.SCH 72209
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20200331_cal.xml EX-101.CAL 46906
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20200331_def.xml EX-101.DEF 480789
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20200331_lab.xml EX-101.LAB 505958
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20200331_pre.xml EX-101.PRE 517012
84 EXTRACTED XBRL INSTANCE DOCUMENT d843470d10q_htm.xml XML 3298852
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 20856353
SIC: 2834 Pharmaceutical Preparations